Search

everythinglearnresearchcommunity

for

Search:↓

The combination of azelaic acid, minoxidil, and caffeine significantly increased the survival of skin flaps by affecting certain body channels and nitric oxide levels.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Skin issues are common in people with neurodegenerative diseases.

The ILDS Newsletter reported on efforts to support albinism patients in Tanzania and dermatological conferences.

Alopecia areata involves specific gene changes and immune pathways, offering new treatment targets.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

The pituitary gland functions normally even after losing most SOX2+ stem cells.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

A portable device can create nanofibers to improve the appearance of thinning hair better than commercial products.

European dermatological guidelines vary in quality, with some highly rated, but improvements are needed in applicability and consistency.

Carbamazepine can cause hair loss, which may reverse when the medication is stopped.

The Korean study found that twenty-nail dystrophy mainly affects adults, more often women, and has five distinct types with different clinical progressions.

A man was diagnosed with a rare form of lupus after showing unique skin symptoms that responded well to treatment.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

Gingivitis may increase a hormone linked to ovarian function in women with a certain ovary condition, and treating gum disease could help manage it.

Skin infections and eczema were most common in all ages, acne in teens and young adults, and nutritional skin problems and infestations in children.

Early detection and treatment of primary biliary cirrhosis and related autoimmune diseases improve outcomes.

Nearly half of the French individuals surveyed reported having a sensitive scalp, more common in women, often linked to hair loss and symptoms like itching, and triggered by factors including shampoos and pollution.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Blood pressure drugs can cause skin lupus, early treatment is key for baby herpes and diabetic foot ulcers, a certain vaccine works against genital herpes and HPV in women, more frequent light therapy helps psoriasis, smoking and drinking can worsen psoriasis, a cream clears up a type of skin cancer, and low iron levels don't cause chronic hair loss.

The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Higher minoxidil concentration (5%) works better for severe hair loss, with most patients seeing regrowth in 48-60 weeks.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.